APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 325 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,603,448 | -57.2% | 41,800 | -34.5% | 0.00% | -62.5% |
| Q1 2024 | $3,750,164 | -9.6% | 63,800 | -8.0% | 0.01% | -11.1% |
| Q4 2023 | $4,150,154 | +18.2% | 69,331 | -24.9% | 0.01% | 0.0% |
| Q3 2023 | $3,510,331 | +10.7% | 92,280 | +165.2% | 0.01% | 0.0% |
| Q2 2023 | $3,169,916 | +50.5% | 34,796 | +9.0% | 0.01% | +80.0% |
| Q1 2023 | $2,105,707 | -34.8% | 31,924 | -48.9% | 0.01% | -50.0% |
| Q4 2022 | $3,231,875 | +15.4% | 62,500 | +52.4% | 0.01% | +11.1% |
| Q3 2022 | $2,801,000 | +4.6% | 41,000 | -30.7% | 0.01% | 0.0% |
| Q2 2022 | $2,677,000 | +71.1% | 59,200 | +92.1% | 0.01% | +80.0% |
| Q1 2022 | $1,565,000 | -31.5% | 30,818 | -55.5% | 0.01% | -37.5% |
| Q3 2021 | $2,284,000 | +55.8% | 69,300 | +198.8% | 0.01% | +33.3% |
| Q2 2021 | $1,466,000 | +53.7% | 23,196 | -20.6% | 0.01% | 0.0% |
| Q2 2020 | $954,000 | +56.7% | 29,225 | +28.7% | 0.01% | +50.0% |
| Q1 2020 | $609,000 | +6.3% | 22,708 | +21.4% | 0.00% | 0.0% |
| Q4 2019 | $573,000 | – | 18,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
| Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
| Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
| Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
| Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
| Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
| GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
| Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
| Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
| Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |